HEXPOL AB Share Price Nasdaq Stockholm
Equities
HPOLb
SE0002452623
Specialty Chemicals
Sales 2024 * | 21.73B 2.01B 160B | Sales 2025 * | 22.83B 2.11B 168B | Capitalization | 44.05B 4.07B 325B |
---|---|---|---|---|---|
Net income 2024 * | 2.68B 248M 19.78B | Net income 2025 * | 2.82B 261M 20.8B | EV / Sales 2024 * | 2.07 x |
Net Debt 2024 * | 1.02B 94.35M 7.52B | Net Debt 2025 * | 558M 51.6M 4.11B | EV / Sales 2025 * | 1.95 x |
P/E ratio 2024 * |
16.4
x | P/E ratio 2025 * |
15.6
x | Employees | - |
Yield 2024 * |
3.07% | Yield 2025 * |
3.32% | Free-Float | 74.74% |
Latest transcript on HEXPOL AB
Managers | Title | Age | Since |
---|---|---|---|
Peter Karl Rosén
CEO | Chief Executive Officer | 56 | 30/11/19 |
Carsten Rüter
CTO | Chief Tech/Sci/R&D Officer | 53 | 31/12/96 |
Public Communications Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 31/10/07 | |
Chairman | 67 | 31/12/06 | |
Director/Board Member | 57 | 31/12/15 |
1st Jan change | Capi. | |
---|---|---|
0.00% | 20.21B | |
-10.54% | 5.47B | |
+3.50% | 1.37B | |
-8.46% | 1.13B | |
+26.88% | 1.02B | |
-13.35% | 687M | |
-24.77% | 670M | |
-15.60% | 284M | |
-2.49% | 262M |